The tumour suppressor CYLD regulates the p53 DNA damage response
Open Access
- 26 August 2016
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 12508
Abstract
The tumour suppressor CYLD is a deubiquitinase previously shown to inhibit NF-κB, MAP kinase and Wnt signalling. However, the tumour suppressing mechanisms of CYLD remain poorly understood. Here we show that loss of CYLD catalytic activity causes impaired DNA damage-induced p53 stabilization and activation in epithelial cells and sensitizes mice to chemical carcinogen-induced intestinal and skin tumorigenesis. Mechanistically, CYLD interacts with and deubiquitinates p53 facilitating its stabilization in response to genotoxic stress. Ubiquitin chain-restriction analysis provides evidence that CYLD removes K48 ubiquitin chains from p53 indirectly by cleaving K63 linkages, suggesting that p53 is decorated with complex K48/K63 chains. Moreover, CYLD deficiency also diminishes CEP-1/p53-dependent DNA damage-induced germ cell apoptosis in the nematode Caenorhabditis elegans. Collectively, our results identify CYLD as a deubiquitinase facilitating DNA damage-induced p53 activation and suggest that regulation of p53 responses to genotoxic stress contributes to the tumour suppressor function of CYLD.Keywords
This publication has 57 references indexed in Scilit:
- Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificityNature Structural & Molecular Biology, 2015
- Signatures of mutation and selection in the cancer genomeNature, 2010
- Regulation of Early Wave of Germ Cell Apoptosis and Spermatogenesis by Deubiquitinating Enzyme CYLDDevelopmental Cell, 2007
- Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaCancer Cell, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- Reduced expression of CYLD in human colon and hepatocellular carcinomasCarcinogenesis, 2007
- Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κBNature, 2003
- CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family membersNature, 2003
- The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitinationNature, 2003
- Identification of the familial cylindromatosis tumour-suppressor geneNature Genetics, 2000